Continued long-term mepolizumab in severe eosinophilic asthma protects from asthma worsening versus stopping mepolizumab: COMET trial

被引：6

作者：

Bel, Elisabeth H. D. ^{[1
]}

Moore, Wendy C. ^{[2
]}

Kornmann, Oliver ^{[3
]}

Poirier, Claude ^{[4
]}

Kaneko, Nirihiro ^{[5
]}

Smith, Steven G. ^{[6
]}

Martin, Neil ^{[7
,8
]}

Gilson, Martyn J. ^{[9
]}

Price, Robert G. ^{[10
]}

Bradford, Eric S. ^{[6
]}

Humbert, Marc ^{[11
,12
,13
]}

机构：

[1] Univ Amsterdam, Dept Resp Med, Amsterdam UMC, Amsterdam, Netherlands

[2] Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC 27101 USA

[3] IKF Pneumol Frankfurt, Clin Res Ctr Resp Dis, Frankfurt, Germany

[4] Ctr Hosp Univ Montreal CHUM, Dept Med, Serv Pneumol, 1051 Sanguinet, Montreal, PQ, Canada

[5] Kameda Med Ctr, Dept Pulm Med, Kamogawa, Japan

[6] GlaxoSmithKline, Resp Med Franchise, Res Triangle Pk, NC USA

[7] GlaxoSmithKline, Global Med Affairs, Brentford, Middx, England

[8] Univ Leicester, Inst Lung Hlth, Leicester, Leics, England

[9] GlaxoSmithKline, Resp Res & Dev, Uxbridge, Middx, England

[10] GlaxoSmithKline, Biostat, Stevenage, Herts, England

[11] Univ Paris Saclay, Le Kremlin Bicetre, France

[12] Hop Bicetre, AP HP, Serv Pneumol & Soins Intensifs Resp, Le Kremlin Bicetre, France

[13] INSERM U999, Paris, France

来源：

关键词：

Asthma; -; management; Severe asthma;

D O I：

10.1183/13993003.congress-2020.5280

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

5280

引用

页数：3